FindTrial
Sign In

Analysis of treatment options for patients with severe COVID-19 patients

Analysis of treatment options for patients with severe COVID-19 patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300070486
Enrollment
Unknown
Registered
2023-04-13
Start date
2023-05-01
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

novel coronavirus pneumonia (COVID-19)

Interventions

case series:NONE

Sponsors

Shanghai Tenth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Adult patients, no gender limit; 2. The diagnosis and treatment protocol for novel coronavirus pneumonia (Trial Version 9) should meet the standards for light, normal, severe and critical cases.

Exclusion criteria

Exclusion criteria: Pregnant and lactating patients.

Design outcomes

Primary

MeasureTime frame
Bacterial infections;28-day mortality;Treatment protocol;—

Secondary

MeasureTime frame
Clinical symptoms at admission;—

Countries

China

Contacts

Public ContactLi Yingchuan

Shanghai Tenth People's Hospital

yingchuan.li@sjtu.edu.cn+86 13681945425

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026